Live Breaking News & Updates on Teprotumumab Pooled Efficacy

Stay updated with breaking news from Teprotumumab pooled efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Horizon Therapeutics plc Announces Data from the TEPEZZA® (teprotumumab-trbw) Phase 4 Clinical Trial in Patients with Chronic/Low CAS Thyroid Eye Disease (TED) to be Presented at the Upcoming Endocrine Society (ENDO) Annual Meeting

TEPEZZA Phase 4 trial results to be shared in an oral presentation on Saturday, June 17 at 3:30 p.m. CT

Two patients will share their real-world experience living with TED and being. | June 5, 2023 ....

Olmsted County , United States , Jeffreyw Sherman , Malini Gupta , Duke University Health System , European Group On Grave Orbitopathy , Drug Administration , Endocrine Society , Horizon Therapeutics , Thyroid Eye Disease , Safety Results , Placebo Controlled Multicenter Trial , Oral Presentation , Multicenter Trial , Hearing Related Issues Associated , Grave Disease , Hearing Related Adverse Events , Teprotumumab Oncology Clinical Trials , Teprotumumab Pooled Efficacy , European Study Sites Participating , Inactive Thyroid Eye Disease Patient Journey , Eye Disease , Early Diagnosis , Duke University Health , Treatment Experience , Exhibit Hall ,